ENTITY
Esco Lifesciences Group

Esco Lifesciences Group (1891571D SP)

2
Analysis
Health CareSingapore

Refresh
26 Apr 2023 00:42

Esco Lifesciences (1891571D SP) Pre-IPO: A Profitable Revenue Growth Saga

Esco Lifesciences is looking to raise $300M through HK IPO. During 2019–2021, by leveraging on demand for its products, the company recorded...

Logo
1.1k Views
Share
30 Nov 2022 12:59

Esco Lifesciences Pre-IPO Tearsheet

Esco Lifesciences Group (1891571D SP) is looking to raise about US$300m in its upcoming HK IPO. The deal will be run by JP Morgan, BofA and Jefferies.

Logo
Ethan Aw
501 Views
Share
x